Instituto Universitario de Tecnologías Biomédicas
Forschungsinstitut
Javier
Ampuero Herrojo
Publikationen, an denen er mitarbeitet Javier Ampuero Herrojo (10)
2024
-
Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice
Alimentary Pharmacology and Therapeutics
-
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
Journal of Gastroenterology
2022
-
Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomes
Gut, Vol. 71, Núm. 10, pp. 2138-2140
2021
-
Clinical Characteristics and Outcome of Drug-Induced Liver Injury in the Older Patients: From the Young-Old to the Oldest-Old
Clinical Pharmacology and Therapeutics, Vol. 109, Núm. 4, pp. 1147-1158
-
Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects
Liver International, Vol. 41, Núm. 9, pp. 2076-2086
-
Effectiveness and safety of obeticholic acid in a Southern European multicentre cohort of patients with primary biliary cholangitis and suboptimal response to ursodeoxycholic acid
Alimentary Pharmacology and Therapeutics, Vol. 53, Núm. 4, pp. 519-530
2020
2019
-
Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD)
Revista Española de Enfermedades Digestivas, Vol. 111, Núm. 4, pp. 264-269
2018
-
Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry
Clinical Gastroenterology and Hepatology, Vol. 16, Núm. 9, pp. 1495-1502